These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

147 related items for PubMed ID: 29870387

  • 1. Nitric Oxide Attenuates Arterial Pulse Wave Reflection in a Vasodilator Responding Pulmonary Arterial Hypertension Patient.
    Su J, Hughes AD, Simonsen U, Howard LS.
    Circ Cardiovasc Interv; 2018 Mar; 11(3):e006242. PubMed ID: 29870387
    [No Abstract] [Full Text] [Related]

  • 2. Pulmonary vascular effects of pulsed inhaled nitric oxide in COPD patients with pulmonary hypertension.
    Hajian B, De Backer J, Vos W, Van Holsbeke C, Ferreira F, Quinn DA, Hufkens A, Claes R, De Backer W.
    Int J Chron Obstruct Pulmon Dis; 2016 Mar; 11():1533-41. PubMed ID: 27462149
    [Abstract] [Full Text] [Related]

  • 3. Acute vasodilator effects of inhaled fasudil, a specific Rho-kinase inhibitor, in patients with pulmonary arterial hypertension.
    Fujita H, Fukumoto Y, Saji K, Sugimura K, Demachi J, Nawata J, Shimokawa H.
    Heart Vessels; 2010 Mar; 25(2):144-9. PubMed ID: 20339976
    [Abstract] [Full Text] [Related]

  • 4. Pulmonary vasodilation by phosphodiesterase 5 inhibition is enhanced and nitric oxide independent in early pulmonary hypertension after myocardial infarction.
    van Duin RWB, Houweling B, Uitterdijk A, Duncker DJ, Merkus D.
    Am J Physiol Heart Circ Physiol; 2018 Feb 01; 314(2):H170-H179. PubMed ID: 28986358
    [Abstract] [Full Text] [Related]

  • 5. Current and Future Treatments for Persistent Pulmonary Hypertension in the Newborn.
    Pedersen J, Hedegaard ER, Simonsen U, Krüger M, Infanger M, Grimm D.
    Basic Clin Pharmacol Toxicol; 2018 Oct 01; 123(4):392-406. PubMed ID: 29855164
    [Abstract] [Full Text] [Related]

  • 6. Comparison of inhaled nitric oxide and inhaled aerosolized prostacyclin in the evaluation of heart transplant candidates with elevated pulmonary vascular resistance.
    Haraldsson A, Kieler-Jensen N, Nathorst-Westfelt U, Bergh CH, Ricksten SE.
    Chest; 1998 Sep 01; 114(3):780-6. PubMed ID: 9743166
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Pulmonary Vascular Capacitance is Associated with Vasoreactivity and Long-Term Response to Calcium Channel Blockers in Idiopathic Pulmonary Arterial Hypertension.
    Cheng XL, He JG, Liu ZH, Gu Q, Ni XH, Zhao ZH, Luo Q, Xiong CM.
    Lung; 2016 Aug 01; 194(4):613-8. PubMed ID: 27272652
    [Abstract] [Full Text] [Related]

  • 9. Combined effects of nitric oxide and oxygen during acute pulmonary vasodilator testing.
    Atz AM, Adatia I, Lock JE, Wessel DL.
    J Am Coll Cardiol; 1999 Mar 01; 33(3):813-9. PubMed ID: 10080486
    [Abstract] [Full Text] [Related]

  • 10. Inhaled Fasudil Lacks Pulmonary Selectivity in Thromboxane-Induced Acute Pulmonary Hypertension in Newborn Lambs.
    Hanson SFL, Terry MH, Moretta DT, Power GG, Wilson SM, Alam F, Ahsan F, Blood AB, Giri PC.
    J Cardiovasc Pharmacol Ther; 2018 Sep 01; 23(5):472-480. PubMed ID: 29756460
    [Abstract] [Full Text] [Related]

  • 11. Hemodynamic and gas exchange effects of inhaled iloprost in patients with COPD and pulmonary hypertension.
    Wang L, Jin YZ, Zhao QH, Jiang R, Wu WH, Gong SG, He J, Liu JM, Jing ZC.
    Int J Chron Obstruct Pulmon Dis; 2017 Sep 01; 12():3353-3360. PubMed ID: 29200842
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Effect of aliskiren treatment on endothelium-dependent vasodilation and aortic stiffness in essential hypertensive patients.
    Virdis A, Ghiadoni L, Qasem AA, Lorenzini G, Duranti E, Cartoni G, Bruno RM, Bernini G, Taddei S.
    Eur Heart J; 2012 Jun 01; 33(12):1530-8. PubMed ID: 22450428
    [Abstract] [Full Text] [Related]

  • 15. Selective and sustained pulmonary vasodilation with inhalational nitric oxide therapy in a child with idiopathic pulmonary hypertension.
    Kinsella JP, Toews WH, Henry D, Abman SH.
    J Pediatr; 1993 May 01; 122(5 Pt 1):803-6. PubMed ID: 8496766
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Hemodynamic effects of inhaled nitric oxide using pulse delivery and continuous delivery systems in pulmonary hypertension.
    Kitamukai O, Sakuma M, Takahashi T, Nawata J, Ikeda J, Shirato K.
    Intern Med; 2002 Jun 01; 41(6):429-34. PubMed ID: 12135173
    [Abstract] [Full Text] [Related]

  • 18. Efficacy and safety of oral sildenafil in children with Down syndrome and pulmonary hypertension.
    Beghetti M, Rudzinski A, Zhang M.
    BMC Cardiovasc Disord; 2017 Jul 04; 17(1):177. PubMed ID: 28676038
    [Abstract] [Full Text] [Related]

  • 19. Inhaled nitric oxide selectively dilates pulmonary vasculature in adult patients with pulmonary hypertension, irrespective of etiology.
    Krasuski RA, Warner JJ, Wang A, Harrison JK, Tapson VF, Bashore TM.
    J Am Coll Cardiol; 2000 Dec 04; 36(7):2204-11. PubMed ID: 11127462
    [Abstract] [Full Text] [Related]

  • 20. Acute Vasodilator Response in Pediatric Pulmonary Arterial Hypertension: Current Clinical Practice From the TOPP Registry.
    Douwes JM, Humpl T, Bonnet D, Beghetti M, Ivy DD, Berger RM, TOPP Investigators.
    J Am Coll Cardiol; 2016 Mar 22; 67(11):1312-23. PubMed ID: 26988953
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.